1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. United States >
  5. New Mexico >
  6. Altaris Acquires OSO BioPharmaceuticals Manufacturing

M&A Deal Summary

Altaris Acquires OSO BioPharmaceuticals Manufacturing

On May 20, 2008, private equity firm Altaris acquired medical products company OSO BioPharmaceuticals Manufacturing

Acquisition Highlights
  • This is Altaris’ 6th transaction in the Medical Products sector.
  • This is Altaris’ 8th transaction in the United States.
  • This is Altaris’ 1st transaction in New Mexico.
Investment Fate
  • OSO BioPharmaceuticals Manufacturing was sold to a publicly-traded strategic buyer in 2014 for 110M USD.

M&A Deal Summary
Date 2008-05-20
Target OSO BioPharmaceuticals Manufacturing
Sector Medical Products
Buyer(s) Altaris
Deal Type Buyout (LBO, MBO, MBI)

Target

OSO BioPharmaceuticals Manufacturing

Albuquerque, New Mexico, United States
OsoBio is a leading contract manufacturer of injectable pharmaceutical products. The company provides glass vial filling and lyophilization services for drugs and biologics that are either approved for commercial marketing or in clinical development. With facilities equipped to handle highly potent and toxic active pharmaceutical ingredients, OsoBio focuses on the production of products that require special or complex handling.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Altaris

New York City, New York, United States

Investor Investor Investor

Category Private Equity Firm
Founded 2003
PE ASSETS 10.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.

DEAL STATS #
Overall 9 of 39
Sector: Medical Products M&A 6 of 13
Type: Buyout (LBO, MBO, MBI) M&A Deals 2 of 7
State: New Mexico M&A 1 of 1
Country: United States M&A 8 of 36
Year: 2008 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-07 Precyse

Wayne, Pennsylvania, United States

Precyse is a provider of outsourced medical transcription, medical coding, and other document management services to U.S. based hospitals and other healthcare providers. The company also provides healthcare facilities with cutting-edge, outsourced administrative functions. Precyse was founded in 1999 and is based in Wayne, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-20 U.S. HealthWorks

Valencia, California, United States

U.S. HealthWorks is a provider of occupational healthcare services in the United States. The Company offers solutions for employers that are seeking to control workers’ compensation costs, minimize lost employee work time, maintain healthy workplaces and strengthen productivity. USHW also provides non-injury occupational health services including job-site analysis, drug and alcohol testing and employment-related physical examinations.

Buy $175M
Mergr

Solution for

Product

Company

Legal